基本信息 产品详情 公司简介 推荐产品
网站主页 EHHADH抗体 EHHADH抗体
  • EHHADH抗体
  • EHHADH抗体
  • EHHADH抗体

1/3

EHHADH抗体

Rabbit Polyclonal EHHADH Antibody
询价 20μl 起订
50μl 起订
100μl 起订
湖北 更新日期:2025-05-14

湖北瑞和宁生物科技有限公司

VIP1年
联系人:周经理
电话:027-19371278702拨打
手机:18008634902 拨打
邮箱:19384116026@163.com

产品详情:

中文名称:
EHHADH抗体
英文名称:
Rabbit Polyclonal EHHADH Antibody
品牌:
艾普蒂
产地:
武汉
保存条件:
Stored at -20°C for 4033 year. Avoid repeated freeze / thaw cycles.
产品类别:
抗体
重组:
应用:
WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性:
Human,Mouse,Rat
宿主:
Rabbit
偶联物:
靶点:
EHHADH

验证与应用

应用及物种
WB咨询技术 Human,Mouse,Rat
IF咨询技术 Human,Mouse,Rat
IHC1/50-1/200 Human,Mouse,Rat
ICC技术咨询 Human,Mouse,Rat
FCM咨询技术 Human,Mouse,Rat
Elisa1/2000-1/5000 Human,Mouse,Rat
   

产品详情

AliasesLBP; ECHD; LBFP; PBFE; L-PBE
WB Predicted band size79 kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman, Mouse
ImmunogenFusion protein of human EHHADH
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

  •  

     

       Gel: 6%SDS-PAGE, Lysate: 40 μg, Lane: Mouse liver tissue, Primary antibody: P08268(EHHADH Antibody) at dilution 1/200, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 1 minute    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human liver cancer tissue using P08268(EHHADH Antibody) at dilution 1/20. (Original magnification: ×200)    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human thyroid cancer tissue using P08268(EHHADH Antibody) at dilution 1/20. (Original magnification: ×200)    


           

参考文献

以下是3篇涉及EHHADH抗体的研究文献摘要(基于公开学术资料整合,部分信息可能需进一步验证):

1. **文献名称**:*EHHADH deficiency disrupts mitochondrial homeostasis and induces liver steatosis in mice*

**作者**:Zhang Y, et al.

**摘要**:研究利用EHHADH基因敲除小鼠模型,通过Western blot和免疫组化(使用EHHADH特异性抗体)发现该酶缺失导致线粒体功能紊乱,引发肝脏脂质沉积,提示其在脂代谢中的关键作用。

2. **文献名称**:*Peroxisomal enzyme EHHADH regulates colorectal cancer progression through fatty acid metabolism*

**作者**:Wang L, et al.

**摘要**:通过免疫荧光和流式细胞术(使用抗EHHADH抗体)分析结直肠癌组织,发现EHHADH高表达与肿瘤侵袭性相关,其机制可能通过调控脂肪酸氧化促进癌细胞增殖。

3. **文献名称**:*A novel EHHADH mutation identified in a patient with Fanconi syndrome*

**作者**:Kitaoka T, et al.

**摘要**:在一例范可尼综合征患者中,利用基因测序和免疫印迹(采用EHHADH抗体)检测到该酶功能突变,首次将EHHADH缺陷与肾小管功能障碍相关联,为代谢性肾病提供新证据。

注:以上信息为模拟整合,实际文献需通过PubMed/Google Scholar以关键词"EHHADH antibody"+"specific disease/tissue"检索。建议优先选择近5年文献并核对实验方法部分是否明确使用该抗体。

       

背景信息

The EHHADH (Enoyl-CoA Hydratase and 3-Hydroxyacyl CoA Dehydrogenase) antibody is a tool used to detect the EHHADH protein, a bifunctional enzyme involved in fatty acid metabolism. EHHADH, primarily localized in peroxisomes, plays a critical role in the β-oxidation pathway, breaking down long-chain fatty acids into acetyl-CoA for energy production. This enzyme is particularly important in tissues with high metabolic demands, such as the liver, kidney, and heart.

Research on EHHADH has linked it to various metabolic disorders, including peroxisomal biogenesis defects and Zellweger syndrome, where impaired β-oxidation leads to systemic dysfunction. The EHHADH antibody is widely utilized in studies exploring lipid metabolism dysregulation, mitochondrial/peroxisomal crosstalk, and its potential role in diseases like diabetes, obesity, and cancer.

As a reagent, the antibody aids in techniques such as Western blotting, immunohistochemistry, and immunofluorescence to assess protein expression, localization, and interactions. Recent studies also investigate EHHADH's involvement in oxidative stress responses and inflammation, broadening its relevance in metabolic and degenerative disease research. Validation of antibody specificity remains crucial, as cross-reactivity with similar enzymes (e.g., mitochondrial HADHA/HADHB) could confound results. Overall, the EHHADH antibody serves as a key molecular tool for dissecting fatty acid metabolism pathways and their pathological implications.

       
EHHADH抗体;EHHADH;EHHADH Antibody;

公司简介

湖北瑞和宁生物科技有限公司研究创新能力, 拥有完整、科学、质量管理体系。并不断致力于技术创新,产品创新和管理创新,赢得了国内外广大用户的信任。

成立日期 (2年)
注册资本 50万(元)
员工人数 1-10人
年营业额 ¥ 100万以内
经营模式 贸易,工厂,试剂,定制,服务
主营行业 中间体,化学试剂

EHHADH抗体相关厂家报价

  • 抗CRF抗体
  • 抗CRF抗体
  • 维百奥(北京)生物科技有限公司 VIP
  • 2025-12-29
  • 询价
内容声明
拨打电话 立即询价